MoneyWorks4Me

SMS Pharmaceuticals informs about credit rating

02 Sep 2026 Evaluate

Pursuant to 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that the CARE Ratings vide their letter No. CARE/HRO/RL/2026-27/1219 dated 01st September, 2026 has reaffirmed/revised its ratings assigned to the bank facilities of the Company. The company has enclosed the summary of ratings for the Company. The rating letter received from CARE Ratings (CARE) is attached as Annexure.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..